These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33830022)

  • 21. Likelihood of Proceeding to Allogeneic Hematopoietic Cell Transplantation in the United States after Search Activation in the National Registry: Impact of Patient Age, Disease, and Search Prognosis.
    Dehn J; Chitphakdithai P; Shaw BE; McDonald AA; Devine SM; Burns LJ; Spellman S
    Transplant Cell Ther; 2021 Feb; 27(2):184.e1-184.e13. PubMed ID: 33045385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
    Barker JN; Krepski TP; DeFor TE; Davies SM; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2002; 8(5):257-60. PubMed ID: 12064362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
    Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
    Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval.
    Rodríguez-Arbolí E; Márquez-Malaver FJ; Rodríguez-Torres N; Caballero-Velázquez T; Escamilla-Gómez V; Calderón-Cabrera C; Falantes-González JF; Solé-Rodríguez M; García-Ramírez P; Moya-Arnao M; Carreras E; Espigado-Tocino I; Pérez-Simón JA
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):183-190. PubMed ID: 30153492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrelated hematopoietic stem cell donor registries: present reality and future prospects.
    Schmidt AH
    Curr Opin Hematol; 2024 Nov; 31(6):251-260. PubMed ID: 39046928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
    Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
    Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
    [No Abstract]   [Full Text] [Related]  

  • 27. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
    MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.
    Confer D; Robinett P
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S3-S5. PubMed ID: 18724295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID-19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
    Othman J; Aarons D; Bajel A; Butler J; Doocey R; O'Brien T; Purtill D; Smith L; Wilcox L; Hamad N
    Intern Med J; 2023 Mar; 53(3):323-329. PubMed ID: 35833788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.
    Verneris MR; Lee SJ; Ahn KW; Wang HL; Battiwalla M; Inamoto Y; Fernandez-Vina MA; Gajewski J; Pidala J; Munker R; Aljurf M; Saber W; Spellman S; Koreth J
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1783-9. PubMed ID: 26055300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
    Bertz H; Spyridonidis A; Ihorst G; Engelhardt M; Grüllich C; Wäsch R; Marks R; Finke J
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):894-902. PubMed ID: 22108569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center.
    Giammarco S; Sica S; Metafuni E; Limongiello MA; Valentini CG; Sorà F; Marra JD; Bacigalupo A; Teofili L; Chiusolo P
    Transfus Apher Sci; 2023 Aug; 62(4):103708. PubMed ID: 37003931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
    Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
    Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of the SARS-CoV-2 pandemic and COVID-19 on lung transplantation in the UK: Lessons learned from the first wave.
    Hardman G; Sutcliffe R; Hogg R; Mumford L; Grocott L; Mead-Regan SJ; Nuttall J; Dunn S; Seeley P; Clark S; Quigley R; Al-Attar N; Booth K; Dark JH; Fisher AJ;
    Clin Transplant; 2021 Mar; 35(3):e14210. PubMed ID: 33368697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unrelated donor bone marrow transplantation for hematological malignancies-current status.
    Davies SM; Wagner JE; Weisdorf DJ; Shu XO; Blazar BR; Enright H; McGlave PB; Ramsay NK
    Leuk Lymphoma; 1996 Oct; 23(3-4):221-6. PubMed ID: 9031102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
    Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a best graft source of transplantation in acute myeloid leukemia?
    Ballen KK
    Best Pract Res Clin Haematol; 2015; 28(2-3):147-54. PubMed ID: 26590772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.